A Phase 1, Double-Blind, Randomized, Placebo-Controlled, First in Human Study of PRAX-330 to Assess the Safety, Tolerability and Pharmacokinetics of Single Ascending Oral Doses in Healthy Subjects
A Phase 1 Trial in Healthy Participants to Evaluate the Pharmacokinetics, Safety, Tolerability and Food Effects of Multiple Formulations of PRAX-114
A Phase 1, Double-Blind, Placebo-Controlled, Randomized Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple-Ascending Doses of PRAX-114 in Healthy Subjects
100 Clinical Results associated with Praxis Precision Medicines Australia Pty Ltd.
0 Patents (Medical) associated with Praxis Precision Medicines Australia Pty Ltd.
100 Deals associated with Praxis Precision Medicines Australia Pty Ltd.
100 Translational Medicine associated with Praxis Precision Medicines Australia Pty Ltd.